The Over-the-Counter Drugs Market is predicted to reach US$ 169.1 billion by 2030 from US$ 169.1 billion in 2021, and to grow at a CAGR of ~8.2% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Products (Analgesics & Pain Relievers, Cough, Cold & Flu Products, Vitamin & Mineral Supplements, Gastrointestinal Products, Dermatological Products, Ophthalmic Products, Sleep Aids, Weight Loss/Dietary Supplements, and Smoking Cessation Aids and Others), by Distribution Channels (Drug Stores & Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Johnson & Johnson, Novartis AG, Teva Pharmaceuticals, GlaxoSmithKline plc, Bayer AG, PGT Healthcare, Pfizer Inc., Boehringer Ingelheim, Merck KGaA, Reckitt Benckiser Group PLC., Glenmark Pharmaceuticals Ltd., Sanofi-Aventis U.S. LLC, and Takeda Pharmaceutical Company Limited, among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Over-the-Counter Drugs - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Over-the-Counter Drugs - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Over-the-Counter Drugs - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Over-the-Counter Drugs - ANALYSIS & FORECAST, BY REGION
North America Over-the-Counter Drugs
1. North America Over-the-Counter Drugs , by Country
1. US
2. Canada
1. North America Over-the-Counter Drugs , by Product
2. North America Over-the-Counter Drugs , by Type
3. North America Over-the-Counter Drugs , by Gender
4. North America Over-the-Counter Drugs , by Sales Channel
3. Europe Over-the-Counter Drugs
1. Europe Over-the-Counter Drugs , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Over-the-Counter Drugs , by Product
3. Europe Over-the-Counter Drugs , by Type
4. Europe Over-the-Counter Drugs , by Gender
5. Europe Over-the-Counter Drugs , by Sales Channel
4. Asia Pacific Over-the-Counter Drugs
1. Asia Pacific Over-the-Counter Drugs , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Over-the-Counter Drugs , by product
3. Asia Pacific Over-the-Counter Drugs , by Type
4. Asia Pacific Over-the-Counter Drugs , by Gender
5. Asia Pacific Over-the-Counter Drugs , by Sales Channel
5. Rest of the World Over-the-Counter Drugs
1. Rest of the World Over-the-Counter Drugs , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Over-the-Counter Drugs , by Product
3. Rest of the World Over-the-Counter Drugs , by Type
4. Rest of the World Over-the-Counter Drugs , by Gender
5. Rest of the World Over-the-Counter Drugs , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 66
The Anti-fishy Smell Syndrome Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Antitumor ADC Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/p...
The Monoamine Oxidase Inhibitors(MAOIs) Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive land...
The Blood Cancer Chemotherapy Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Veterinary Antibacterial Prescription Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The Antitumor Peptide Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacture...
The Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, comp...
The Endocrinology Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/p...
The Opthalmic Pharmaceutical Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Chemosynthetic Polypeptide Drugs Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
